UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 26, 2018

PRAXSYN CORPORATION

(Exact name of registrant as specified in its charter)

Nevada

333-130446

20-3191557

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

	61 Spectrum Blvd., Las Vegas, NV 89101
	(Address of principal executive offices, including zip code)

	(702) 761-3809
	(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02.

Directors.

On September 26, 2018, Dr. Jonathan Renkas submitted his resignation as a director of Praxsyn Corporation, effective September 28, 2018. Dr. Renkas’ resignation was not due to any disagreement or matter relating to the Company’s operations, policies or practices.

SIGNATURE

Pursuant to the requirements of the Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	PRAXSYN CORPORATION

DATE: September 28, 2018	By:	/s/ Frank J. Brady
		Frank J. Brady
		Chief Executive Officer

Praxsyn Corp 8-K